BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Caliway Receives Initial Approval for CBL-514 Phase 3 Fat Reduction Study

"We are all delighted to see CBL-514 showing its potential to become the new, promising, non-invasive fat reduction treatment in the previous Pha...

January 24, 2024 | News

Sagimet Biosciences Reports Positive Results in Phase 2b Trial of Denifanstat for F2/F3 NASH

- Primary efficacy endpoints: NASH resolution without worsening of fibrosis with ≥2-point reduction in NAS (NAFLD Activity Score) in ...

January 24, 2024 | News

Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay

In a significant move, Agappe and Fujirebio have revealed plans to launch these products in June 2024. The project has already achieved significant progres...

January 22, 2024 | News

Complete Genomics and Gencove Partner for Bundled Low-Pass Whole Genome Sequencing Solution at PAG 31

The partnership will combine Gencove's platform for data analytics and management with Complete Genomics' sequencing products and automation capabilit...

January 17, 2024 | News

SOPHiA GENETICS and Karkinos Healthcare Partner to Advance Cancer Research in India

SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge geno...

January 15, 2024 | News

VerImmune and A*STAR Join Forces in Research Collaboration to Propel ViP Platform Development

The collaboration is centered around platform development and aims to develop a preclinical manufacturing platform, which will facilitate the generation of...

January 11, 2024 | News

Shanghai Argo Partners with Novartis in Multi-Program RNAi Licensing and Collaboration

- Argo will receive upfront payments of $185 million from Novartis and is eligible to receive potential option and milestone payments as wel...

January 08, 2024 | News

Kexing Biopharm Expands Global Portfolio with Eribulin Mesylate Injection

Eribulin Mesylate Injection is indicated for patients with locally advanced or metastatic breast cancer who have undergone at least two chemotherapy r...

January 08, 2024 | News

MediLink Therapeutics Partners with Roche for Oncology Antibody Drug Conjugate

Under the terms of the agreement, MediLink will grant Roche exclusive global rights for the development, manufacturing, and commercialization of MediLink's...

January 03, 2024 | News

NeuroBo Pharma Seeks FDA Approval for Obesity Treatment Trial

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, anno...

January 02, 2024 | News

Biocytogen and CtM Bio Advance in Developing Multi-Specific T Cell Engager against WT1/HLA-A02

In just one year since the start of the collaboration, the companies have identified a WT1/HLA-A02-specific T cell engager (WT1xCD3x4-1BB tri-specific anti...

December 28, 2023 | News

CStone sells to Servier its exclusive rights to TIBSOVO® in Greater China and Singapore

The deal enables CStone to prioritize its resources to focus on the development of first-in-class and best-in-class therapies with global rights. T...

December 22, 2023 | News

NUS Researchers in Singapore Innovate Flexible Method for Immune Cell Study

Our body's immune system is a complex network of organs, cells, and proteins that work in synchrony to protect our bodies against infections caused by path...

December 19, 2023 | News

GeneQuantum and BioMap Collaborate on Next-Gen ADC Therapeutics

The partnership will combine GQ's proprietary enzymatic site-specific conjugation technology platforms (iLDC® and iGDC®), linker-payload platform, ...

December 18, 2023 | News

Stay Connected